Jubilant Radiopharma

Access Bio Inc, located in Somerset, NJ, is a leader in the development of in vitro diagnostic technologies aimed at improving global health. The company specializes in a comprehensive portfolio of products for infectious disease diagnosis, with a notable focus on malaria, HIV, HPV, and COVID-19. Recognized as a trusted partner to international public health agencies, Access Bio has successfully commercialized high-quality detection kits and diagnostic tests, including rapid and PCR tests. Their mission is driven by a commitment to enhancing the lives and wellbeing of people worldwide through innovative and adaptable solutions. Generated from the website

DRG International is one of the leading providers of medical diagnostics and equipment. The company, founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor with representation in more than 80 countries through a network of DRG subsidiaries and local distributors. The DRG staff of medical, clinical, marketing and service specialists are experienced in supplying cost effective innovative products and systems to our customers worldwide. Located west of New York in Mountainside, N.Y., DRG corporate headquarters provides logistic and financial management support to DRG subsidiaries overseas and coordinates the DRG distributor network.

Bracco, the parent company of Bracco Diagnostics, was founded in 1927. It has been owned and operated for three generations by the Bracco family. The company is an integrated health care group and a world leader in global solutions for the diagnostic imaging field. Born as a pharmaceuticals trading concern, the company has developed an independent industrial production and research activity, specializing its research and development capacities in a specific field - diagnostic imaging. Bracco's laboratories discovered and developed the iopamidol molecule, the first ready-to-use non-ionic contrast medium. In 1994, the company expanded into the United States. It founded Bracco Diagnostics and Bracco Research USA in Princeton, N.J. The United States represents the group's largest market in the sector of contrast agents for medical diagnostics.